Patrick J. Christmas's Net Worth
$6.29 Million
Who is Patrick J. Christmas?
Patrick J. Christmas has an estimated net worth of $6.29 Million. This is based on reported shares across multiple companies, which include REGENXBIO Inc., and KV PHARMACEUTICAL CO /DE/.
SEC CIK
Patrick J. Christmas's CIK is 0001521123
Past Insider Trading and Trends
2018 was Patrick J. Christmas's most active year for acquiring shares with 11 total transactions. Patrick J. Christmas's most active month to acquire stocks was the month of December. 2018 was Patrick J. Christmas's most active year for disposing of shares, totalling 24 transactions. Patrick J. Christmas's most active month to dispose stocks was the month of December. 2018 saw Patrick J. Christmas paying a total of $877,505.38 for 114,865 shares, this is the most they've acquired in one year. In 2018 Patrick J. Christmas cashed out on 141,528 shares for a total of $3,621,180.20, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
REGENXBIO Inc. (RGNX) Snapshot price: $11.48
Chief Legal Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +30.01% | 26.72K |
$17.95 | -$141,679.35 | 115.76K |
Jan 2
| |||
Form 4
| +288.13% | 66.1K |
$22.68 | -$41,799.24 | 89.04K |
Jan 3
| |||
Form 4
| +40.12% | 6.57K |
$32.70 | -$43,556.40 | 22.94K |
Jan 1 - Jan 3
| |||
Form 4
|
—
|
0
|
$30.59 | -$173,842.98 | 16.37K |
Scheduled
|
Feb 12
| ||
Form 4
|
—
|
0
|
$30.61 | -$48,113.00 | 16.37K |
Scheduled
|
Feb 8
| ||
Form 4
|
—
|
0
|
$28.45 | -$326,880.00 | 16.37K |
Scheduled
|
Feb 2
| ||
Form 4
|
—
|
0
|
$30.81 | -$745,331.84 | 16.37K |
Scheduled
|
Jan 8 - Jan 12
| ||
Form 4
| +536.55% | 13.8K |
—
|
—
| 16.37K |
Jan 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 2
| |||
Form 4
| -15.89% | -486.00 |
$27.05 | -$169,912.00 | 2.57K |
Scheduled
|
Sep 12
| ||
Form 4
| +1.73% | 52 |
$34.86 | -$150,731.84 | 3.06K |
Scheduled
|
Jun 30 - Jul 19
| ||
Form 4
|
—
|
0
|
$32.55 | -$204,464.70 | 3.01K |
Scheduled
|
Jun 18
| ||
Form 4
|
—
|
0
|
$33.74 | -$194,864.55 | 3.01K |
Scheduled
|
Apr 18
| ||
Form 4
| +12.63% | 337 |
$35.66 | $12,016.58 | 3.01K |
Dec 31 - Jan 3
| |||
Form 4
|
—
|
0
|
$29.82 | -$177,197.90 | 2.67K |
Scheduled
|
Dec 18
| ||
Form 4
| -84.89% | -15.00K |
$72.06 | -$1,080,900.00 | 2.67K |
Scheduled
|
Nov 7
| ||
Form 4
|
—
|
0
|
$36.94 | -$248,390.30 | 17.67K |
Scheduled
|
Oct 18
| ||
Form 4
|
—
|
0
|
$39.03 | -$269,306.00 | 17.67K |
Scheduled
|
Aug 20
| ||
Form 4
| +9.47% | 1.53K |
$34.44 | -$204,897.20 | 17.67K |
Scheduled
|
Jun 18 - Jun 19
| ||
Form 4
| +1,314.64% | 15K |
$27.72 | -$287,000.00 | 16.14K |
Scheduled
|
May 9 - May 10
| ||
Form 4
|
—
|
0
|
$25.55 | -$269,000.00 | 1.14K |
Scheduled
|
Apr 11
| ||
Form 4
|
—
|
0
|
$23.05 | -$219,000.00 | 1.14K |
Scheduled
|
Apr 9
| ||
Form 4
|
∞
| 1.14K |
$16.45 | $18,768.43 | 1.14K |
Jun 30 - Jan 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 18
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
KV PHARMACEUTICAL CO /DE/ No price found
General Counsel
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Jun 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||